TENTANG EPISODE INI

Inggris
Australia

DALAM EPISODE INI

TRANSKRIP 🔗

CARI EPISODE TERDAHULU

Cari episode sebelumnya dari Morgans Under the Microscope.

EPISODE LAIN DALAM PODCAST INI

Scott Power from the Morgans Healthcare team speaks with Peter Rowland, CEO from Micro-X (ASX: MX1) where he explains the technology, its application, and upcoming catalysts for 2021.
Morgans Healthcare Analyst Iain Wilkie talks to Pippa Leary, Chief Executive Officer of Swift Media (ASX:SW1) for a high-level overview of the business, catalysts, and its shift into the large aged care sector.
Morgans analyst Iain Wilkie speaks with Chief Executive Officer and Managing Director of ResApp (ASX:RAP), Tony Keating. Tony provides an update on a number of recent news events.Check out more from Morgans:Visit the Morgans website: www.morgans.com.auCheck out our blog: www.morgans.com.au/BlogOn F…
Morgans Senior Analysis, Dr. Derek Jellinek, provides an update on the healthcare universe, including key upcoming catalysts.Check out more from Morgans:Visit the Morgans website: www.morgans.com.auCheck out our blog: www.morgans.com.au/BlogOn Facebook: www.facebook.com/MorgansAUOn Instagram: www.i…
Healthcare analysts Iain Wilkie and Scott Power wrap up the week with a review and call out on stocks in the IVF sector such as: Virtus Health (VRT) and Monash IVF Group (MVF). Some other stocks mentioned are ImexHS (IME), Swift Media (SW1), and Impedimed (IPD).
Sanggahan: Podcast dan karya seni yang disematkan pada halaman ini berasal dari Morgans Financial Limited, yang merupakan milik pemiliknya dan tidak berafiliasi atau didukung oleh Listen Notes, Inc.